Dorsalgia

M13_DORSALGIA

causalgia: Complex regional pain syndrome type 2 (CRPS2), or causalgia is a form of complex regional pain syndrome that develops after damage to a peripheral nerve and is characterized by spontaneous pain, allodynia and hyperalgesia , not necessarily limited to the territory of the injured nerve, as well as at some point, edema, changes in skin blood flow or sudomotor dysfunction in the pain area.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

77552

6. Filter based on genotype QC (FinnGen only)

74560

Control definitions (FinnGen only)

Control exclude M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 664590 374723 284844
Only index persons 606243 347970 258273
Unadjusted period prevalence (%)
Whole population 9.50 10.73 7.96
Only index persons 11.54 12.79 9.86
Median age at first event (years)
Whole population 49.25 50.79 47.30
Only index persons 48.17 49.67 46.15

-FinnGen-

Key figures

All Female Male
Number of individuals 74560 45974 28586
Unadjusted period prevalence (%) 16.64 18.06 14.36
Median age at first event (years) 50.49 49.02 52.85

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Mortality – FinRegistry

Association

Association between endpoint M13_DORSALGIA and mortality.

Females

Parameter HR [95% CI] p-value
M13_DORSALGIA 1.296 [1.19, 1.42] < 0.001
Birth year 0.992 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 39788 out of 277239 females with M13_DORSALGIA died.

Males

Parameter HR [95% CI] p-value
M13_DORSALGIA 1.454 [1.32, 1.6] < 0.001
Birth year 0.984 [0.98, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 30339 out of 202472 males with M13_DORSALGIA died.

Mortality risk

Mortality risk for people of age

years, who have M13_DORSALGIA.

N-year risk Females Males
1 0.137% 0.252%
5 0.593% 1.451%
10 1.498% 3.659%
15 2.995% 6.699%
20 5.084% 11.529%

Relationships between endpoints

Index endpoint: M13_DORSALGIA – Dorsalgia

GWS hits: 14

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data